View on market: Stay Cautious, be with quality business:

Asian stocks fluctuated while U.S futures fell as traders weighed potential slowdown in the global economy and China’s measures to boost growth. Equities were volatile in Japan, Australia and South Korea. Nasdaq futures tumble after Snap Inc. said it would not meet revenue and profit forecasts for the second quarter. Futures of Meta Platforms Inc. and Alphabet Inc. tumbled following Snap’sstatement. The Singapore-traded SGX Nifty, an early barometer of India’s benchmark Nifty 50, rose nearly 0.5% to 16,253 points as of 6:30 am. In focus today are U.S. President Joe Biden’s comments that China tariffs imposed by the Trump administration are being reviewed. Elsewhere, West Texas Intermediate crude fell 0.5% to $109.74 a barrel. Bitcoin fell nearly 4% to $29,000.

Economic Calendar:

  • INR: FX Reserve on 27thMay
  • INR: GDP Quartely on 31st May 2022.
  • USD: Chicago Fed National Activity 24th May, 2022.
  • USD: Manufacturing PMI 24th May, 2022.

Earnings Today: Adani Ports, Grasim Industries, Zee Media Corporation, Balrampur Chini, Dalmia Bharat Sugar and Industries, Ipca Laboratories, Jyothy Labs, RITES, Strides Pharma Science, Gujarat Alkalies and Chemicals, Asian Granito, e-Clerx Services, Bank of India, Aster DM Healthcare, Minda Industries, Metropolis Healthcare.

Q4Fy22 Earning:

Steel Authority of India Q4 FY22 (Consolidated, YoY) Revenue up 32.1% at Rs 30,758.82 crore EBITDA down 29.52% at Rs 4,337.56 crore EBITDA margin at 14.1% vs 26.43% Net profit down 28.56% at Rs 2,478.82 crore Recommended final dividend of Rs 2.25 per share

Zomato Q4 FY22 (YoY) Revenue up 75% at Rs 1,211 crore EBITDA loss at Rs 449 crore vs EBITDA loss of Rs 154 crore Net loss at Rs 360 crore vs net losss at Rs 134 crore Gross Order Value at Rs 585 crore vs Rs 331 crore Average monthly transacting customers: 1.57 crore vs 0.98 crore

Bharat Electronics Q4 FY22 (Consolidated, YoY) Revenue down 8.35% at Rs 6,339.81 crore EBITDA down 20.36% at Rs 1,577.53 crore EBITDA margin at 24.88% vs 28.64% Net profit at 15.63% at Rs 1,154.2 crore Recommended final dividend of Rs 1.5 per share

Ramco Cements Q4 FY22 (Consolidated, YoY) Revenue up 4.88% at Rs 1713.4 crore EBITDA down 34.32% at Rs 294.90 crore EBITDA margin at 17.21% vs 27.48% Net profit down 45.15% at Rs 118.57 crore Recommended dividend of Rs 3 per share

BirlaSoft Q4 FY22 (Consolidated, QoQ) Revenue up 2.76% at Rs 1101.44 crore EBIT up 7.35% at Rs 154.58 crore EBIT margin at 14.03% Vs 13.43% Net profit up 16.61% at Rs 132.89 crore Recommended final dividend of Rs 3 per share Approved buyback of up 78 lakh shares at Rs 500 apiece

Brokerage Radar:

MORGAN STANLEY ON ZOMATO: OW, TP Rs 135 Qtry nos in line to better, with improved transparency on segment disclosures, better outlook for 1Q, & a tighter framework around capital allocation With these results, co is moving in the right direction although it needs consistent execution.

UBS ON ZOMATO: Buy, TP Rs 130 Q4: Healthy qtr despite reopening headwinds Co’s disclosures have also improved this quarter, which is a positive Believe growth drivers continue to remain strong.

CITI ON RAMCO CEMENT: Sell, TP cut to Rs 600 from Rs 650 4Q EBITDA Ahead; Maintain Sell on Industry Pricing Outlook Think overall industry pricing trends should remain muted In absence of substantial cement price acceleration, net D/EBITDA could remain high.

GOLDMAN SACHS ON DIVIS LABS: Buy, TP Rs 4850 Strong 4Q beat While co did not quantify Molnupiravir contribution, our calculations suggest c.$250m sales in FY22 (21% of sales) Key debate on stock has been sustainability of this revenue stream Cut FY23/24E EPS est by 3-8%

International Markets:

U.S & Europe:

Particulars       23rd May    Chg Chg(%)
Nasdaq 11,535.28 180.66      1.59
Dow 31880.24 618.34      1.98
FTSE 7,513.44 123.46 1.67
CAC 6,358.74 73.5 1.17
DAX 14,175.40 193.49 1.38
Dow Fut.* 31740.80    -140. 00      -0.44

Asian markets:

Particulars    24th May    Chg. Chg(%)
SGX Nifty 16,205.00 29.5 0.18
Nikkei 26,863.33 -138.19 -0.51
Straits Times 3,215.19 1.54 0.05
Hang Seng 20,247.48 -222.58 -1.09
Shanghai 3,138.91 -7.95 -0.25

ADR Watch:

Particulars     23rd May Chg. Chg.(%)
Dr Reddy 55.07 0.04 0.07
HDFC Bank 53.64 -0.16 -0.3
ICICI Bank 18.45 0.35 1.93
Infosys 18.89 0.19 1.02
Tata Motor 27.38 0.62 2.32
Wipro 6.04 0.1 1.68

Commodities & Currency:

Particulars Current Price Chg(%)
USD/INR 77.52  -0.04
Brent 110.22     -0.53
Gold 1850.03    0.12
Silver 21.727    0.02


Particulars         23rd May                                  20th May
FIIs -1951.17                               -1265.41                         
DIIs         1445.39        2148.95

News Update

Maruti Suzuki: The carmaker has bought 12.09% stake in AI software company Sociograph Solutions for Rs 1.99 crore to create customised sales experience on the web, and in virtual and augmented reality.

Marico: The consumer goods maker has acquired 53.98% stake in healthy breakfast and snack company HW Wellness.

Natco Pharma: FMC Corporation has filed a suit against the company for a Process Patent in Delhi High court. The patent covers a process to prepare Chlorantraniliprole that is set to expire on Dec. 6, 2025.

Disclosure in pursuance of Section 19 of SEBI (RA) Regulation 2014

Elite Wealth Limited does/does not do business with companies covered in its research reports. Investors should be aware that the Elite Wealth Limited may/may not have a conflict of interest that could affect the objectivity of this report. Investors should consider this report as only information in making their investment decision and must exercise their own judgment before making any investment decision.
For analyst certification and other important disclosures, see the Disclosure Appendix, or go to Analysts employed by Elite Wealth Limited are registered/qualified as research analysts with SEBI in India.( SEBI Registration No.: INH100002300)
Disclosure Appendix
Analyst Certification (For Reports)
Israil Khan, Elite Wealth Limited,
The analyst(s) certify that all of the views expressed in this report accurately reflect my/our personal views about the subject company or companies and its or their securities. I/We also certify that no part of my compensation was, is or will be, directly or indirectly, related to the specific recommendations or views expressed in this report. Unless otherwise stated, the individuals listed on the cover page of this report are analysts in Elite Wealth Limited.
As to each individual report referenced herein, the primary research analyst(s) named within the report individually certify, with respect to each security or issuer that the analyst covered in the report, that:
(1) all of the views expressed in the report accurately reflect his or her personal views about any and all of the subject securities or issuers; and
(2) no part of any of the research analyst’s compensation was, is, or will be directly or indirectly related to the specific recommendations or views expressed in the report.
For individual analyst certifications, please refer to the disclosure section at the end of the attached individual notes.
Research Excerpts
This note may include excerpts from previously published research. For access to the full reports, including analyst certification and important disclosures, investment thesis, valuation methodology, and risks to rating and price targets, please visit
Company-Specific Disclosures
Important disclosures, including price charts, are available and all Elite Wealth Limited covered companies by visiting, or emailing with your request. Elite Wealth Limited may screen companies based on Strategy, Technical, and Quantitative Research. For important disclosures for these companies, please e-mail
Options related research:
If the information contained herein regards options related research, such information is available only to persons who have received the proper option risk disclosure documents. For a copy of the risk disclosure documents, please contact your Broker’s Representative or visit the OCC’s website at
Other Disclosures
All research reports made available to clients are simultaneously available on our client websites. Not all research content is redistributed, e-mailed or made available to third-party aggregators. For all research reports available on a particular stock, please contact your respective broker’s sales person.
Ownership and material conflicts of interest Disclosure
Elite Wealth Limited policy prohibits its analysts, professionals reporting to analysts from owning securities of any company in the analyst’s area of coverage. Analyst compensation: Analysts are salary based permanent employees of Elite Wealth Limited. Analyst as officer or director: Elite Wealth Limited policy prohibits its analysts, persons reporting to analysts from serving as an officer, director, board member or employee of any company in the analyst’s area of coverage.
Country Specific Disclosures
India – For private circulation only, not for sale.
Legal Entities Disclosures
Mr. Ravinder Parkash Seth is the Managing Director of Elite Wealth Ltd (EWL, henceforth), having its registered office at Casa Picasso, Golf Course Extension, Near Rajesh Pilot Chowk, Radha Swami, Sector-61, Gurgaon-122001 Haryana, is a SEBI registered Research Analyst and is regulated by Securities and Exchange Board of India. Telephone:011-43035555, Facsimile: 011-22795783 and Website:
EWL discloses all material information about itself including its business activity, disciplinary history, the terms and conditions on which it offers research report, details of associates and such other information as is necessary to take an investment decision, including the following:
1. Reports
a) EWL or his associate or his relative has no financial interest in the subject company and the nature of such financial interest;
(b) EWL or its associates or relatives, have no actual/beneficial ownership of one per cent. or more in the securities of the subject company, at the end of the month immediately preceding the date of publication of the research report or date of the public appearance;
(c) EWL or its associate or his relative, has no other material conflict of interest at the time of publication of the research report or at the time of public appearance;
2. Compensation
(a) EWL or its associates have not received any compensation from the subject company in the past twelve months;
(b) EWL or its associates have not managed or co-managed public offering of securities for the subject company in the past twelve months;
(c) EWL or its associates have not received any compensation for investment banking or merchant banking or brokerage services from the subject company in the past twelve months;
(d) EWL or its associates have not received any compensation for products or services other than investment banking or merchant banking or brokerage services from the subject company in the past twelve months;
(e) EWL or its associates have not received any compensation or other benefits from the Subject Company or third party in connection with the research report.
3 In respect of Public Appearances
(a) EWL or its associates have not received any compensation from the subject company in the past twelve months;
(b) The subject company is not now or never a client during twelve months preceding the date of distribution of the research report and the types of services provided by EWL